We are proud of and thankful for prominent scientists and clinicians who have decided to dedicate some of their academic time to research on Moleac’s products through initiatives such as the CHIMES trial. As academic partners, they are fully independent.
SCIENTIFIC ADVISORY BOARD
Prof Michel Lazdunski, CNRS France Gold Medal– World renowned specialist in pharmacology of ion channels
Prof Christopher Chen, National University of Singapore, Chairman of the CHIMES Trial Steering Committee, Principal Investigator of NEURITES Trial
Prof Marie-Germaine Bousser, Former Head of Neurology at Lariboisiere Hospital, France, investigator of CHIMES Trial
Dr Catherine Heurteaux, Principal Investigator at IPMC
Prof Geoffrey Donnan, National Stroke Institute, University of Melbourne, Australia
Prof Hossein Pakdaman, Shahid Behesti University, Tehran
Dr Valery Feigin, Director of the National Institute for Stroke and Applied Neurosciences (NISAN), New Zealand
Prof Professor Lawrence Wong, Head of Department of Medicine and Therapeutics, Hong Kong
